The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (16.33) USD. With the latest stock price at 11.76 USD, the upside of Exagen Inc based on DCF is -238.9%.
Based on the latest price of 11.76 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 238.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.9% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (86.56) - (9.25) | (16.33) |
| Upside | -836.0% - -178.7% | -238.9% |